Immediate Impact

66 standout
Sub-graph 1 of 22

Citing Papers

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
2024 Standout
2 intermediate papers

Works of Simon Gross being referenced

Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes
2015

Author Peers

Author Last Decade Papers Cites
Simon Gross 149 57 290 154 8 501
Chikage Sato 112 47 279 169 9 540
Daisho Hirota 103 77 317 130 6 509
Hyun Wha Chung 136 37 207 226 13 564
Hidemitsu Sakagami 68 42 204 205 13 509
Markus Daschner 117 19 190 172 12 456
Skander Mulder 168 18 326 149 8 535
M. M. Okamoto 94 22 299 177 12 466
Narayanan Nampoory 161 29 142 115 12 437
J.L. Paul 90 33 135 112 18 561
Yi‐Chih Lin 156 20 131 115 14 456

All Works

Loading papers...

Rankless by CCL
2026